Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011061 · ClinicalTrials.gov registry record
Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography
A clinical trial, sponsored by Rigshospitalet, Denmark.
- Completed
- Registry status
- 182
- Enrollment target
NCT02011061: Completed study, sponsored by Rigshospitalet, Denmark.
NCT02011061 is a clinical trial that has completed, run by Rigshospitalet, Denmark. The registered enrollment target is 182 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02011061 has completed, sponsored by Rigshospitalet, Denmark.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
Study Summary
Coronary calcium hampers accurate evaluation of the coronary arteries with coronary computed tomography angiography (CCTA). A novel approach to potentially overcome this limitation is coronary calcium subtraction. The primary hypothesis of the study is: \- Coronary calcium subtraction CCTA will improve diagnostic accuracy as compared to conventional CCTA on a per-patient basis
Primary Outcome
Sensitivity, Specificity, Negative and Positive predictive value of Coronary Subtraction CT angiography by visual assessment to identify a \>50% coronary stenosis as defined by invasive coronary angiography on a patient by patient level.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-06 |
What the finished NCT02011061 record still lists
NCT02011061 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02011061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02011061 about?
NCT02011061 is a clinical study titled "Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography". Coronary calcium hampers accurate evaluation of the coronary arteries with coronary computed tomography angiography (CCTA). A novel approach to potentially overcome this limitation is coronary calcium subtraction. The primary hypothesis of the study is: \- Coronary calcium subtraction CCTA will im...
What is the current status of trial NCT02011061?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2013-10. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT02011061?
This trial is sponsored by Rigshospitalet, Denmark, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia